TREM2 and cancer: Even though few clinical studies about targeting TREM2 in cancer treatment are conducting now, the potential for clinical translation of TREM2-targeted therapies remains high in the future, and numerous possible interventions are existed to tackle the TREM2 and its signaling pathway (43).